BACKGROUND: Diagnosis of mitochondrial disorders usually requires a muscle biopsy to examine mitochondrial function. We describe our diagnostic procedure and results for 29 patients with mitochondrial disorders. METHODS: Muscle biopsies were from 43 healthy individuals and 29 patients with defects in one of the oxidative phosphorylation (OXPHOS) complexes, the pyruvate dehydrogenase complex (PDHc), or the adenine nucleotide translocator (ANT). Homogenized muscle samples were used to determine the oxidation rates of radiolabeled pyruvate, malate, and succinate in the absence or presence of various acetyl Co-A donors and acceptors, as well as specific inhibitors of tricarboxylic acid cycle or OXPHOS enzymes. We determined the rate of ATP production from oxidation of pyruvate. RESULTS: Each defect in the energy-generating system produced a specific combination of substrate oxidation impairments. PDHc deficiencies decreased substrate oxidation reactions containing pyruvate. Defects in complexes I, III, and IV decreased oxidation of pyruvate plus malate, with normal to mildly diminished oxidation of pyruvate plus carnitine. In complex V defects, pyruvate oxidation improved by addition of carbonyl cyanide 3-chlorophenyl hydrazone, whereas other oxidation rates were decreased. In most patients, ATP production was decreased. CONCLUSION: The proposed method can be successfully applied to the diagnosis of defects in PDHc, OXPHOS complexes, and ANT.
BACKGROUND: Diagnosis of mitochondrial disorders usually requires a muscle biopsy to examine mitochondrial function. We describe our diagnostic procedure and results for 29 patients with mitochondrial disorders. METHODS: Muscle biopsies were from 43 healthy individuals and 29 patients with defects in one of the oxidative phosphorylation (OXPHOS) complexes, the pyruvate dehydrogenase complex (PDHc), or the adenine nucleotide translocator (ANT). Homogenized muscle samples were used to determine the oxidation rates of radiolabeled pyruvate, malate, and succinate in the absence or presence of various acetyl Co-A donors and acceptors, as well as specific inhibitors of tricarboxylic acid cycle or OXPHOS enzymes. We determined the rate of ATP production from oxidation of pyruvate. RESULTS: Each defect in the energy-generating system produced a specific combination of substrate oxidation impairments. PDHc deficiencies decreased substrate oxidation reactions containing pyruvate. Defects in complexes I, III, and IV decreased oxidation of pyruvate plus malate, with normal to mildly diminished oxidation of pyruvate plus carnitine. In complex V defects, pyruvate oxidation improved by addition of carbonyl cyanide 3-chlorophenyl hydrazone, whereas other oxidation rates were decreased. In most patients, ATP production was decreased. CONCLUSION: The proposed method can be successfully applied to the diagnosis of defects in PDHc, OXPHOS complexes, and ANT.
Authors: Bart W Smits; Frans A Hol; Lambert P van den Heuvel; Gea Drost; Richard J T Rodenburg; Henk J Ter Laak; Baziel G M van Engelen Journal: J Neurol Date: 2007-11-02 Impact factor: 4.849
Authors: Saskia J G Hoefs; Cindy E J Dieteren; Felix Distelmaier; Rolf J R J Janssen; Andrea Epplen; Herman G P Swarts; Marleen Forkink; Richard J Rodenburg; Leo G Nijtmans; Peter H Willems; Jan A M Smeitink; Lambert P van den Heuvel Journal: Am J Hum Genet Date: 2008-06 Impact factor: 11.025
Authors: Steffi van de Ven; Thatjana Gardeitchik; Dorus Kouwenberg; Leo Kluijtmans; Ron Wevers; Eva Morava Journal: J Inherit Metab Dis Date: 2013-10-31 Impact factor: 4.982
Authors: An I Jonckheere; Marije Hogeveen; Leo Nijtmans; Mariel van den Brand; Antoon Janssen; Heleen Diepstra; Frans van den Brandt; Bert van den Heuvel; Frans Hol; Tom Hofste; Livia Kapusta; U Dillmann; M Shamdeen; J Smeitink; J Smeitink; Richard Rodenburg Journal: BMJ Case Rep Date: 2009-01-23
Authors: G Herma Renkema; Saskia B Wortmann; Roel J Smeets; Hanka Venselaar; Marion Antoine; Gepke Visser; Tawfeg Ben-Omran; Lambert P van den Heuvel; Henri J L M Timmers; Jan A Smeitink; Richard J T Rodenburg Journal: Eur J Hum Genet Date: 2014-04-30 Impact factor: 4.246
Authors: John F O'Toole; Yangjian Liu; Erica E Davis; Christopher J Westlake; Massimo Attanasio; Edgar A Otto; Dominik Seelow; Gudrun Nurnberg; Christian Becker; Matti Nuutinen; Mikko Kärppä; Jaakko Ignatius; Johanna Uusimaa; Salla Pakanen; Elisa Jaakkola; Lambertus P van den Heuvel; Henry Fehrenbach; Roger Wiggins; Meera Goyal; Weibin Zhou; Matthias T F Wolf; Eric Wise; Juliana Helou; Susan J Allen; Carlos A Murga-Zamalloa; Shazia Ashraf; Moumita Chaki; Saskia Heeringa; Gil Chernin; Bethan E Hoskins; Hassan Chaib; Joseph Gleeson; Takehiro Kusakabe; Takako Suzuki; R Elwyn Isaac; Lynne M Quarmby; Bryan Tennant; Hisashi Fujioka; Hannu Tuominen; Ilmo Hassinen; Hellevi Lohi; Judith L van Houten; Agnes Rotig; John A Sayer; Boris Rolinski; Peter Freisinger; Sethu M Madhavan; Martina Herzer; Florence Madignier; Holger Prokisch; Peter Nurnberg; Peter K Jackson; Peter Jackson; Hemant Khanna; Nicholas Katsanis; Friedhelm Hildebrandt Journal: J Clin Invest Date: 2010-02-22 Impact factor: 14.808
Authors: Paulien Smits; Hana Antonicka; Peter M van Hasselt; Woranontee Weraarpachai; Wolfram Haller; Marieke Schreurs; Hanka Venselaar; Richard J Rodenburg; Jan A Smeitink; Lambert P van den Heuvel Journal: Eur J Hum Genet Date: 2010-12-01 Impact factor: 4.246
Authors: M C de Vries; R J Rodenburg; E Morava; M Lammens; L P W van den Heuvel; G Christoph Korenke; J A M Smeitink Journal: J Inherit Metab Dis Date: 2008-05-20 Impact factor: 4.982